Haug Partners LLP

Firm logo for Haug Partners LLP

Withdrawal of bupropion hydrochloride extended-release 300 mg by Watson

16/10/2013 Based on data submitted by Watson Pharmaceuticals Inc. ("Watson") (recently merged with Actavis Inc. ("Actavis")), FDA announced last week that…

The Supreme Court’s Decision in Alice Corp. v. CLS Bank Has Taken a Heavy Toll on Patents for Computer-Related Inventions

16/02/2016 The patent statue broadly defines patent-eligible subject matter as "any new and useful process, machine, manufacture, or composition of matter" and…

Physical attributes of generic tablets and capsules guidance issued by FDA

10/12/2013 On December 9, 2013, FDA issued a new draft guidance: Size, Shape, and Other Physical Attributes of Generic Tablets and Capules. FDA said that it…

A Balancing Act: Fair Use and Creative Content

24/07/2017 This article analyzes a trend in the entertainment field where a party wishing to use another’s intellectual property in a creative work will do so…

After Several Unsuccessful Attempts by Apple, an Injunction Will Soon Prohibit Samsung from Infringing Apple Patents

05/02/2016 Years after Apple started a long-running patent battle against Samsung, an injunction will become…

See more articles

Haug Partners LLP


  • USA

    • New York NY

      10th Floor, 745 Fifth Avenue, New York NY 10151, USA
      T +1 212 588 0800F +1 212 588 0500
    • Boston MA

      One Post Office Square, Floor 31, Boston MA 02109, USA
      T +1 617 426 6800